Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCHW) EPS (Weighted Average and Diluted) (2022 - 2025)

Historic EPS (Weighted Average and Diluted) for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to -$0.35.

  • Envoy Medical's EPS (Weighted Average and Diluted) rose 1025.64% to -$0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.36, marking a year-over-year decrease of 1623.93%. This contributed to the annual value of -$1.49 for FY2024, which is 4146.46% up from last year.
  • Per Envoy Medical's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.35 for Q3 2025, which was up 1025.64% from -$0.32 recorded in Q2 2025.
  • Envoy Medical's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.23 during Q1 2022, with a 5-year trough of -$1.31 in Q1 2023.
  • Moreover, its 4-year median value for EPS (Weighted Average and Diluted) was -$0.35 (2025), whereas its average is -$0.43.
  • Within the past 5 years, the most significant YoY rise in Envoy Medical's EPS (Weighted Average and Diluted) was 20000.0% (2023), while the steepest drop was 228093.26% (2023).
  • Envoy Medical's EPS (Weighted Average and Diluted) (Quarter) stood at -$1.13 in 2022, then surged by 55.0% to -$0.51 in 2023, then grew by 19.54% to -$0.41 in 2024, then rose by 14.73% to -$0.35 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.35 for Q3 2025, versus -$0.32 for Q2 2025 and -$0.29 for Q1 2025.